No Data
No Data
Earnings Preview: CGTX to Report Financial Results Pre-market on March 20
Cognition Therapeutics, Inc. Transitions to Nasdaq Capital Market Following Compliance Notification
Cognition Therapeutics Granted Extension To Meet Nasdaq Minimum Bid Price Requirement
Cognition Therapeutics Granted Extension to Meet Nasdaq Minimum Bid Price Requirement for Continued Exchange Listing
Life Sciences Investor Forum Agenda Announced for March 13th
Cognition Therapeutics to Present at Life Sciences Virtual Investor Conference